- 優先名称
- 4-[1-[(9E,19E,21E)-13-acetyloxy-2,15,17-trihydroxy-3,7,12,14,16,22-hexamethyl-11-[(4-methyl-4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-yl)oxy]-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-18-yl]ethoxy]-3,3-dimethyl-4-oxobutanoic acid
- IUPAC
- 4-[1-[(9E,19E,21E)-13-acetyloxy-2,15,17-trihydroxy-3,7,12,14,16,22-hexamethyl-11-[(4-methyl-4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-yl)oxy]-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-18-yl]ethoxy]-3,3-dimethyl-4-oxobutanoic acid
- 現地名
- カングレマイシンA
- 英語名
- kanglemycin A
- 分子式
- C50H63NO19
- 分子量
- 982.03
名称と別名
SCHEMBL295504034-[1-[(9E,19E,21E)-13-acetyloxy-2,15,17-trihydroxy-3,7,12,14,16,22-hexamethyl-11-[(4-methyl-4,6,7,7a-tetrahydro-3aH-[1,3]dioxolo[4,5-c]pyran-6-yl)oxy]-6,23,27,29-tetraoxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25-heptaen-18-yl]ethoxy]-3,3-dimethyl-4-oxobutanoic acidカングレマイシンA20-[1-(3-カルボキシ-2,2-ジメチル-1-オキソプロポキシ)エチル]-20-デメチル-27-O-デメチル-1,4-ジデオキシ-27-O-(2,6-ジデオキシ-3-O,4-O-メチレン-β-D-ribo-ヘキソピラノシル)-1,4-ジヒドロ-1,4-ジオキソリファマイシン4-{1-[(7S,9Z,11S,12R,13S,14R,15R,16S,17R,18S,19Z,21Z)-11-{[(3aR,4R,6R,7aS)-4-メチル-ヘキサヒドロ-[1,3]ジオキソロ[4,5-c]ピラン-6-イル]オキシ}-13-(アセチルオキシ)-2,15,17-トリヒドロキシ-3,7,12,14,16,22-ヘキサメチル-6,23,27,29-テトラオキソ-8,30-ジオキサ-24-アザテトラシクロ[23.3.1.14,7.05,28]トリアコンタ-1,3,5(28),9,19,21,25-ヘプタエン-18-イル]エトキシ}-3,3-ジメチル-4-オキソブタン酸kanglemycin A20-[1-(3-Carboxy-2,2-dimethyl-1-oxopropoxy)ethyl]-20-demethyl-27-O-demethyl-1,4-dideoxy-27-O-(2,6-dideoxy-3-O,4-O-methylene-β-D-ribo-hexopyranosyl)-1,4-dihydro-1,4-dioxorifamycin